How VPAM Healthcare is Redefining Pharmaceutical Excellence From Global Approvals to India's Doorstep

Discover how VPAM Healthcare combines global regulatory excellence, 200+ dossier filings, contract manufacturing, and the Dyanama initiative to transform Indian healthcare.

At VPAM Healthcare, the mission has always been clear: serve humanity through medicines that meet the highest standards of quality, safety, and efficacy. What began as a commitment to operational excellence has evolved into a globally recognized pharmaceutical enterprise, one that continues to push boundaries, both internationally and right here at home.

A Global Footprint Built on Regulatory Trust

VPAM Healthcare's credibility in the global pharmaceutical space is anchored in its association with some of the world's most respected regulatory bodies. The company holds accreditations from USFDA, MHRA, EU GMP, PIC/S, and WHO, alongside territorial approvals that span across continents, including:

• Africa: MOH Ethiopia, TFDA (Tanzania), NAFDAC (Nigeria), NDA Uganda, PPB Kenya, DPML Ivory Coast, PMPB Malawi
• Asia-Pacific: MOH Philippines, MOH Cambodia, NMRA Sri Lanka
• Europe & CIS: MOH Azerbaijan, Ukraine, Russia
• Latin America: Digemid Peru

This extensive regulatory network is not just a list of certifications; it's a testament to VPAM's unwavering commitment to delivering medicines that meet globally benchmarked quality standards in every market it serves.

Contract Manufacturing: Bringing Quality to the Domestic Market

VPAM Healthcare recently launched its Contract Manufacturing Division, strategically designed to serve the domestic Indian pharmaceutical market. Through partnerships with certified, high-quality manufacturing facilities, this division offers reliable, scalable production solutions across dosage forms including tablets, capsules, and more.

The division's value proposition is built on three pillars:

• Quality: Every product batch adheres to stringent manufacturing and quality control standards.
• Value: Competitive pricing structures that make high-quality pharma manufacturing accessible.
• Trust: Long-term partnership models built on transparency and consistency.

Whether you're a domestic brand looking for a manufacturing partner or a new entrant seeking a compliant production base, VPAM's Contract Manufacturing Division offers the expertise and infrastructure to bring your formulations to market with confidence.

Introducing Dyanama – Healthcare for Every Indian

One of VPAM's most significant domestic initiatives is Dynama — a thoughtfully built healthcare brand designed to make trusted pharmaceutical solutions more accessible across India.

Dyanama is more than a product line. It's VPAM's answer to the growing demand for affordable, high-quality formulations that address real therapeutic needs without compromising on efficacy or safety. Rooted in VPAM's deep pharmaceutical expertise and regulatory track record, Dyanama brings a carefully curated range of medicines to Indian communities – with a clear focus on:

• Therapeutic value - products chosen for their clinical relevance and patient benefit
• Consistent performance - backed by the same quality standards that power VPAM's export business
• Affordability - ensuring that quality healthcare doesn't remain a privilege

Dynama reflects VPAM's belief that operational excellence and patient accessibility are not trade-offs; they are complementary goals.

200+ Dossiers Filed. 150+ More Underway.

VPAM's global expansion is backed by a robust dossier pipeline. To date, the company has cumulatively filed approximately 200 dossiers across its target markets, with another 150+ dossiers currently in planning stages for near-future submission. This continuous pipeline reflects a systematic, research-backed approach to market access, one that ensures VPAM's products can reach patients wherever they are in the world.

Science-Backed. CRO-Validated.

Quality at VPAM goes beyond manufacturing compliance. The company partners with technically approved Contract Research Organizations (CROs) to conduct rigorous bioavailability and bioequivalence studies for its drug portfolio. These studies ensure that every VPAM product delivers optimal drug absorption and efficacy, translating pharmaceutical science into real clinical outcomes for patients.

This commitment to evidence-based quality sets VPAM apart in a competitive market and reinforces the trust that regulators, partners, and patients place in the brand.

The VPAM Promise

From globally accredited manufacturing to India-first healthcare initiatives, from regulatory filings across 20+ countries to CRO-validated drug performance, VPAM Healthcare's journey is one of purpose-driven growth. Every decision, every partnership, and every product is guided by a single north star: better health outcomes for every patient, everywhere.

To learn more about VPAM's Contract Manufacturing Division, the Dyanama range, or our global regulatory capabilities, visit vpamhealthcare.com.